ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

By | December 16, 2021
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.